ORMP ORAMED PHARMACEUTICALS INC Company Mergers 8-K Filing 2025 - Asset Acquisitions On April 24, 2025, Oramed Pharmaceuticals Inc. completed a purchase agreement to acquire 14,110,121 shares of Alpha Tau Medical at approximately $36.9 million. Additionally, they entered into a strategic services agreement with Alpha Tau for $3 million, offering investor relations services.Get access to all SEC 8-K filings of the ORAMED PHARMACEUTICALS INC